137 related articles for article (PubMed ID: 33414439)
1. Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures.
Raniolo S; Unida V; Vindigni G; Stolfi C; Iacovelli F; Desideri A; Biocca S
Cell Death Dis; 2021 Jan; 12(1):7. PubMed ID: 33414439
[TBL] [Abstract][Full Text] [Related]
2. Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells.
Unida V; Vindigni G; Raniolo S; Stolfi C; Desideri A; Biocca S
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559104
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages.
Raniolo S; Vindigni G; Ottaviani A; Unida V; Iacovelli F; Manetto A; Figini M; Stella L; Desideri A; Biocca S
Nanomedicine; 2018 Jun; 14(4):1181-1190. PubMed ID: 29458213
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
5. In Silico and In Cell Analysis of Openable DNA Nanocages for miRNA Silencing.
Raniolo S; Iacovelli F; Unida V; Desideri A; Biocca S
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861821
[TBL] [Abstract][Full Text] [Related]
6. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
Du G; Cao D; Meng L
Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
Nasser MW; Datta J; Nuovo G; Kutay H; Motiwala T; Majumder S; Wang B; Suster S; Jacob ST; Ghoshal K
J Biol Chem; 2008 Nov; 283(48):33394-405. PubMed ID: 18818206
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
Li L; Zhou L; Li Y; Lin S; Tomuleasa C
J BUON; 2014; 19(1):228-36. PubMed ID: 24659669
[TBL] [Abstract][Full Text] [Related]
9. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
[TBL] [Abstract][Full Text] [Related]
10. Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells.
Wang Z; Wang W; Zhao W; Wang Z; Yang J; Wang W; Teng P; Su X; Li D; Zhang X; Wang H; Hao M
Biomed Pharmacother; 2020 Feb; 122():109654. PubMed ID: 31918266
[TBL] [Abstract][Full Text] [Related]
11. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
Lee TJ; Yoo JY; Shu D; Li H; Zhang J; Yu JG; Jaime-Ramirez AC; Acunzo M; Romano G; Cui R; Sun HL; Luo Z; Old M; Kaur B; Guo P; Croce CM
Mol Ther; 2017 Jul; 25(7):1544-1555. PubMed ID: 28109960
[TBL] [Abstract][Full Text] [Related]
12. Efficient co-delivery of microRNA 21 inhibitor and doxorubicin to cancer cells using core-shell tecto dendrimers formed via supramolecular host-guest assembly.
Song C; Xiao Y; Ouyang Z; Shen M; Shi X
J Mater Chem B; 2020 Apr; 8(14):2768-2774. PubMed ID: 32154812
[TBL] [Abstract][Full Text] [Related]
13. miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells.
Zhang J; Zheng F; Yu G; Yin Y; Lu Q
Biochem Biophys Res Commun; 2013 Nov; 440(4):582-8. PubMed ID: 24120501
[TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate.
Mohammed AFA; Higashi T; Motoyama K; Ohyama A; Onodera R; Khaled KA; Sarhan HA; Hussein AK; Arima H
AAPS J; 2019 Apr; 21(4):54. PubMed ID: 30993472
[TBL] [Abstract][Full Text] [Related]
15. Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin.
Chen W; Zhou Y; Zhi X; Ma T; Liu H; Chen BW; Zheng X; Xie S; Zhao B; Feng X; Dang X; Liang T
Biomaterials; 2019 Feb; 192():590-600. PubMed ID: 30553134
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 494 increases chemosensitivity to doxorubicin in gastric cancer cells by targeting phosphodiesterases 4D.
Peng QP; Du DB; Ming Q; Hu F; Wu ZB; Qiu S
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):62-66. PubMed ID: 30672438
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-mediated knockdown of miR-214 modulates cell fate in response to anti-cancer drugs in HPV-negative and HPVpositive cervical cancer cells.
Sen P; Ghosal S; Hazra R; Mohanty R; Arega S; Sahu B; Ganguly N
J Biosci; 2020; 45():. PubMed ID: 32554905
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
